Group 1 - The core investment philosophy of the fund manager emphasizes "value investment + absolute return," focusing on valuation, cash flow, and fundamental certainty to achieve long-term stable returns [1][14] - The fund adopts a "core + satellite" allocation framework, avoiding trends and focusing on undervalued assets, with a balanced sector allocation to mitigate risks [1][14] - The fund manager has a strong track record, with a total return of 10.71% since taking over the fund, ranking in the top 28.96% among peers [2][23] Group 2 - The fund's asset allocation primarily consists of high-grade credit bonds, with a significant portion (50%-87%) allocated to credit bonds, and a recent increase in interest rate bonds to 21.33% [3][35] - The equity allocation remains below 20%, with an average historical stock position of 13.14%, focusing on large-cap, undervalued, and high-quality stocks [2][40] - The fund's industry allocation is heavily weighted towards electricity and public utilities, maintaining a proportion of 17.84%-28.06% from Q4 2023 to Q2 2025 [2][48] Group 3 - The fund has demonstrated strong performance in controlling drawdowns, with a maximum drawdown of -1.29%, significantly better than the peer average [2][24] - The probability of making a profit after holding the fund for three months is 92.41%, indicating a high success rate for investors [2][29] - The fund manager employs a dynamic stock selection strategy, focusing on large-cap stocks with low valuations and high quality, while maintaining a balanced growth style [2][40]

Group 1 - The core viewpoint of the news is that Morning Light Bio has seen a stock price increase of 5.07%, reaching 13.26 CNY per share, with a total market capitalization of 6.406 billion CNY [1] - Morning Light Bio, established on April 12, 2000, and listed on November 5, 2010, specializes in the research, production, and sales of natural plant extracts, including chili red pigment, lutein, chili oil resin, lycopene, and cottonseed protein [1] - The company's main business revenue composition is as follows: cottonseed-related business accounts for 48.25%, pigment/spice/nutritional and medicinal products account for 47.39%, and others account for 4.35% [1] Group 2 - From the perspective of fund holdings, one fund under China Europe Fund has a significant position in Morning Light Bio, with the China Europe Value Selection Mixed A Fund holding 581,300 shares, representing 2.43% of the fund's net value [2] - The China Europe Value Selection Mixed A Fund has achieved a year-to-date return of 22.87% and a one-year return of 39.76%, ranking 4202 out of 8171 and 3898 out of 8004 respectively [2] - The fund manager, Zhang Xueming, has been in position for 1 year and 157 days, with the fund's total asset size at 1.711 billion CNY and the best return during his tenure being 70.87% [3]

1. Report Industry Investment Rating No relevant content provided in the report. 2. Report's Core View - The CSI 500 index has high - value configuration due to its alignment with the national "new quality productivity" strategy, and its constituent stocks are expected to have significant profit growth, which may digest the current high valuation [3][10][17]. - The CSI 500 index - enhanced funds are a mature product category with a long history, large scale, and the ability to create obvious excess returns. Among them, the China - Europe CSI 500 Index - Enhanced Fund has excellent performance [23][30][31]. - The China - Europe CSI 500 Index - Enhanced Fund has low deviations in constituent stocks, factors, and industries, outstanding performance, strong unique Alpha acquisition ability, good market environment adaptability, and stock - selection as the main source of excess returns [84][85]. 3. Summary by Directory 3.1中证 500 指数配置价值分析 (Analysis of the Allocation Value of the CSI 500 Index) 3.1.1战略方向契合：新质生产力视角下的政策红利 (Strategic Direction Fit: Policy Dividends from the Perspective of New Quality Productivity) - The industry distribution of the CSI 500 index is highly consistent with the national "new quality productivity" strategy. Its constituent stocks cover many high - tech industries, making it a high - quality carrier for policy dividends [10]. - Most of the top - ten constituent stocks of the CSI 500 index are related to the key areas of new quality productivity and can benefit from policy support [13][14]. 3.1.2估值与盈利情况：当前具有良好的配置价值 (Valuation and Profitability: Currently with Good Allocation Value) - As of September 19, 2025, the PE (TTM) of the CSI 500 index is at a relatively high quantile since 2015, but it is in a reasonable range compared with other broad - based indices [15]. - According to Wind's consensus forecast data, the earnings per share of the CSI 500 index constituent stocks are expected to rise significantly in 2025 and 2026, and the net profit is also expected to increase notably, with expected growth rates of 24.7% and 18.1% respectively [17]. - Although the current valuation quantile of the index is high, the future profitability of the constituent stocks is optimistic, and the valuation is expected to be digested with the profit growth [22]. 3.2中证 500 指数增强基金投资价值与策略分析 (Analysis of the Investment Value and Strategy of CSI 500 Index - Enhanced Funds) 3.2.1产品发展情况：较为成熟的品类 (Product Development: A Relatively Mature Category) - The first CSI 500 index - enhanced product in the Chinese public - offering market was established in 2011, with a 14 - year history, accumulating a lot of investment experience [23]. - As of Q2 2025, the total scale of CSI 500 index - enhanced products exceeded 4.3 billion yuan, and the number of products increased from 15 at the end of 2016 to 71, indicating strong market demand and active layout by fund companies [23][26]. 3.2.2历史表现情况：更加明显的超额 (Historical Performance: More Obvious Excess Returns) - Historically, the CSI 500 index - enhanced products have generally created excess returns for investors, except in a few periods when the index rose rapidly [30]. - Compared with the CSI 300 index - enhanced products, the CSI 500 index - enhanced products can create more obvious excess returns, with a higher slope of the relative return curve and generally higher annual excess returns [31]. 3.2.3产品特征分布：中欧中证 500 指数增强独特性、市场环境适应性均较好 (Product Feature Distribution: The China - Europe CSI 500 Index - Enhanced Fund Has Good Uniqueness and Market Environment Adaptability) - Most CSI 500 index - enhanced products have limited ability to obtain unique Alpha, and their Alpha - acquisition methods may be similar, resulting in homogeneous performance. Only a few products can efficiently obtain unique Alpha [38]. - More than 62% of CSI 500 index - enhanced products have obvious shortcomings in market environment adaptability, while only 15% of products can perform in the top 50% in various market environments [42]. - The China - Europe CSI 500 Index - Enhanced Fund can efficiently obtain unique Alpha and has no obvious market environment adaptability shortcomings, performing in the top 40% in all market environments [44]. 3.3中欧中证 500 指数增强产品特征分析 (Analysis of the Product Features of the China - Europe CSI 500 Index - Enhanced Fund) 3.3.1持仓特征：成分股、因子、行业暴露均较小 (Positioning Characteristics: Small Exposure to Constituent Stocks, Factors, and Industries) - The China - Europe CSI 500 Index - Enhanced Fund has a relatively dispersed stock position, with a low proportion of the top - ten and top - thirty holdings. It does not rely on market - value sinking to obtain excess returns, and its market - value style deviation is small [46][51]. - The fund's factor exposure is relatively mild, with exposure to various factors controlled within 0.5 times the standard deviation in the past four full - position periods. The average factor exposure is lower than the sample average [53][55]. - The proportion of CSI 500 constituent stocks in the fund's position is significantly higher than the average of similar products, and the industry deviation from the CSI 500 index is controllable, with the maximum over - or under - allocation ratio not exceeding 6% and further tightened in H1 2025 [55][61]. 3.3.2业绩表现：25 年表现在同类中较为领先 (Performance: Leading Performance Among Peers in 2025) - Since its establishment, the China - Europe CSI 500 Index - Enhanced Fund has outperformed the benchmark index, with a cumulative return of 31.69% as of September 19, 2025, leading the benchmark by 27.77% [63]. - In 2025, the fund's return reached 34.56%, ranking in the top 5% among similar products, with an annualized tracking error of only 3.54%, ranking in the lower 18% [63]. - The fund has a prominent risk - return ratio, with an annualized Sharpe ratio of 2.29 and a Calmar ratio of 4.44, leading among all CSI 500 index - enhanced products [64]. - The fund has significant advantages in drawdown control, with a lower drawdown than the index and the average of similar products in major market drawdowns since 2024, and its maximum relative return drawdown is also significantly lower than the average of similar products [71][75]. 3.3.3收益拆分：选股收益贡献明显 (Return Decomposition: Significant Contribution from Stock - Selection Returns) - The China - Europe CSI 500 Index - Enhanced Fund mainly obtains excess returns through stock - selection, and trading can also contribute part of the excess returns [78]. - The fund's absolute returns come from a wide range of sectors, with the science and technology innovation sector contributing more returns. It can also obtain excess returns in most sectors through stock - selection [80]. 3.3.4产品特征总结 (Product Feature Summary) - The fund has no significant deviations in constituent stocks, factors, and industries, and the deviations in all dimensions tightened in H1 2025 [84]. - Despite strict deviation control, the fund's performance in 2025 is outstanding, with leading returns, small tracking errors, excellent risk - return ratios, and leading drawdown control among similar products [84]. - The fund has outstanding ability to obtain unique Alpha and good market environment adaptability, with no obvious market environment shortcomings [85]. - Stock - selection is the main source of excess returns, with the main stock - selection returns coming from the science and technology innovation sector, and relatively good stock - selection performance in other sectors [85].

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - The CSI 500 Index is highly consistent with the national "new quality productivity" strategy, benefiting from policy dividends and technological innovation [4][12]. - The earnings per share of CSI 500 constituent stocks are expected to rise, and the valuation is likely to be digested with the improvement of earnings [4][20]. - The CSI 500 index enhancement is a relatively mature product with a large scale and obvious excess returns [4][26]. - The China - Europe CSI 500 Index Enhancement has good performance in unique Alpha acquisition and market environment adaptation, with outstanding risk - return characteristics [4][47]. 3. Summary by Directory 3.1 CSI 500 Index Allocation Value Analysis 3.1.1 Strategic Direction Fit: Policy Dividends from the Perspective of New Quality Productivity - The CSI 500 Index, as a core representative of A - share mid - cap enterprises, has a high proportion of technology innovation sectors in its constituent stocks, which are consistent with the key areas in the "Action Plan" [4][12]. - Many of the top - proportion industries in the CSI 500 constituent stocks are in line with the definition of new quality productivity, such as electronics, pharmaceutical biology, and power equipment [12]. - Most of the top ten constituent stocks of the CSI 500 can benefit from the national promotion of new quality productivity [16]. 3.1.2 Valuation and Earnings: Good Current Allocation Value - As of September 19, 2025, the PE (TTM) of the CSI 500 Index was 34.20 times, at the 76.7% quantile since 2015, which is in a reasonable range compared with other broad - based indexes [18]. - According to Wind's consensus forecast, the earnings per share of CSI 500 constituent stocks are expected to significantly recover in 2025, rising from 0.36 yuan in 2024 to 0.49 yuan, an increase of over 38%, and continue to rise in 2026 [20]. - The net profit of the CSI 500 Index is expected to increase significantly in 2025 and 2026, by 24.7% and 18.1% respectively [20]. 3.2 Investment Value and Strategy Analysis of CSI 500 Index Enhancement Funds 3.2.1 Product Development: A Relatively Mature Category - The first CSI 500 index enhancement product in the Chinese public fund market was established in 2011, with 14 years of history, accumulating a lot of investment experience [26]. - As of Q2 2025, the total scale of CSI 500 index enhancement products exceeded 4.3 billion yuan, and the number of products increased from 15 at the end of 2016 to 71 [26][29]. 3.2.2 Historical Performance: More Obvious Excess Returns - Since 2017, the CSI 500 index enhancement products have generally outperformed the CSI 500 Index, except in some periods when the index rose rapidly [32]. - Compared with the CSI 300 index enhancement, the CSI 500 index enhancement can create more obvious excess returns, with a steeper slope of the relative return curve and higher annual excess returns on average [33]. 3.2.3 Product Feature Distribution: Good Uniqueness and Market Environment Adaptability of China - Europe CSI 500 Index Enhancement - Most CSI 500 index enhancement products have limited ability to obtain unique Alpha, and their Alpha sources may be similar, resulting in homogeneous performance [41]. - More than 62% of CSI 500 index enhancement products have obvious shortcomings in market environment adaptability, and only 15% of products can perform in the top 50% in various market environments [45]. - The China - Europe CSI 500 Index Enhancement can efficiently obtain unique Alpha and perform in the top 40% in all market environments [47]. 3.3 Product Feature Analysis of China - Europe CSI 500 Index Enhancement 3.3.1 Positioning Characteristics: Small Exposure to Constituent Stocks, Factors, and Industries - The China - Europe CSI 500 Index Enhancement has a relatively dispersed stock position, with a low proportion of the top ten and top thirty stocks, and low deviation in market - value style [49][54]. - The product has relatively mild factor exposure, with exposure to most factors within 0.3 times the standard deviation, and lower than the average of similar products [56][58]. - The proportion of CSI 500 constituent stocks in the product's position is higher than the average of similar products, and the industry deviation is controllable, especially in H1 2025 [58][64]. 3.3.2 Performance: Leading Performance among Peers in 2025 - As of September 19, 2025, the cumulative return of the China - Europe CSI 500 Index Enhancement since its establishment was 31.69%, leading the benchmark by 27.77%. Since H2 2023, it has outperformed the benchmark [66]. - In 2025, the product's return reached 34.56%, ranking in the top 5% among similar products, with an annualized tracking error of only 3.54%, ranking in the bottom 18% [66]. - The product has a high risk - return ratio, with an annualized Sharpe ratio of 2.29 and a Calmar ratio of 4.44, leading among CSI 500 index enhancement products [67]. - The product has significant advantages in drawdown control, with a smaller drawdown than the index and the average of similar products in several market drawdowns since 2024, and a smaller relative return drawdown [74][78]. 3.3.3 Return Breakdown: Significant Contribution from Stock Selection - The China - Europe CSI 500 Index Enhancement mainly obtains excess returns through stock selection, and trading can also contribute part of the excess returns [81]. - The product's absolute return comes from a wide range of sectors, with the technology innovation sector contributing more, and it can obtain excess returns in most sectors [84]. 3.3.4 Product Feature Summary - The product has no significant deviation in constituent stocks, factors, and industries, and the deviation has further tightened in H1 2025 [89]. - Despite strict deviation control, the product has outstanding performance in 2025, with high returns, low tracking error, and excellent risk - return characteristics [89]. - The product has strong ability to obtain unique Alpha and good market environment adaptability, performing in the top 40% in all market environments [90]. - Stock selection is the main source of excess returns, with significant contributions from the technology innovation sector and good performance in other sectors [90].

Group 1 - The core viewpoint of the news is that Haikang Technology's stock has seen a significant increase, with a rise of 5.15% to 55.38 CNY per share, and a total market capitalization of 62.021 billion CNY [1] - Haikang Technology, established on August 26, 2005, and listed on January 17, 2012, specializes in the research, development, production, and sales of chemical pharmaceuticals [1] - The main revenue composition of Haikang Technology includes anesthetic products (39.81%), cooperative product-related income (23.59%), other indications (17.02%), parenteral nutrition (10.32%), antiemetics for tumors (8.15%), and other supplementary income (0.86%) [1] Group 2 - Among the top ten circulating shareholders of Haikang Technology, a fund under China Europe Fund has increased its holdings by 5.3574 million shares, bringing its total to 21.2763 million shares, which accounts for 4.42% of the circulating shares [2] - The China Europe Medical Health Mixed A Fund (003095) has achieved a year-to-date return of 28.95% and a one-year return of 48.76% [2] - The fund manager, Ge Lan, has a tenure of 10 years and 242 days, with a total fund size of 39.908 billion CNY, achieving a best return of 126.87% during her tenure [3]

中欧基金管理有限公司（以下简称"本公司"）旗下部分基金参加了四川百利天恒药业股份有限公司（百 利天恒，代码：688506）非公开发行股票的认购。根据中国证监会《关于基金投资非公开发行股票等流 通受限证券有关问题的通知》等有关规定，本公司现将旗下基金投资此非公开发行股票的相关信息公告 如下： ■ 注：基金资产净值、账面价值为2025年09月19日数据。 特此公告。 中欧基金管理有限公司 2025年9月23日 MACD金叉信号形成，这些股涨势不错！ ...

Group 1 - The core viewpoint of the articles highlights the increasing interest in secondary bond funds as a stable investment option amidst fluctuating deposit rates and a recovering A-share market [1] - The new fund, China Europe Youli Bond Fund, is set to launch on October 9, aiming to balance risk and return by investing at least 80% in bonds and 5%-20% in equity assets [1] - The fund manager, Huang Hua, has 17 years of experience in the securities industry and has demonstrated strong performance in managing other funds, such as China Europe Shuangli A, which achieved a cumulative return of 41.77% since inception [2][3] Group 2 - The fund's strategy includes capturing enhanced returns during stock market recoveries while maintaining a stable income from bond investments [1] - Huang Hua anticipates structural valuation opportunities in the A-share market due to economic transitions and increased risk appetite, suggesting a shift from a previous downward trend in the bond market to a wider range of fluctuations [2] - The fund's flexible trading strategies and balanced asset allocation aim to seize structural opportunities amidst market volatility [2]

Group 1 - The core point of the news is that Bomin Electronics experienced a decline of 5.07% in its stock price, reaching 13.11 yuan per share, with a trading volume of 640 million yuan and a turnover rate of 7.54%, resulting in a total market capitalization of 8.265 billion yuan [1] - Bomin Electronics, established on March 25, 2005, and listed on December 9, 2015, is located in Meizhou, Guangdong Province. The company specializes in the research, production, and sales of high-precision printed circuit boards (PCBs) and related core electronic components [1] - The main revenue composition of Bomin Electronics includes printed circuit boards at 75.03%, customized electronic components at 21.05%, and other supplementary sources at 3.93% [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under China Europe Fund holds a significant position in Bomin Electronics. The China Europe Small Cap Growth Mixed A Fund (015880) held 347,900 shares in the second quarter, accounting for 0.63% of the fund's net value, ranking as the fourth-largest heavy stock [2] - The China Europe Small Cap Growth Mixed A Fund (015880) was established on June 28, 2022, with a latest scale of 199 million yuan. Year-to-date, it has achieved a return of 53.55%, ranking 873 out of 8172 in its category, and a one-year return of 115.08%, ranking 366 out of 7995 [2] Group 3 - The fund managers of the China Europe Small Cap Growth Mixed A Fund (015880) are Qian Yating and Tang Minwei. As of the report, Qian Yating has a cumulative tenure of 3 years and 326 days, with the fund's total asset scale at 2.377 billion yuan, achieving a best return of 57.29% during the tenure [3] - Tang Minwei has a cumulative tenure of 63 days, with the fund's total asset scale at 517 million yuan, achieving a best return of 14.18% during the tenure [3]

Performance Overview - Since 2025, the annualized excess return median for enhanced index funds is 2.82%, with the 75th percentile reaching 8.21%, significantly higher than levels from 2022 to 2024[11] - The annualized excess return median for broad-based enhanced index funds is 3%, an increase of 0.68% compared to 2024[11] - The China Securities A500 Index has shown a remarkable annualized return of 48.97% over the past year, with a total return index close to 52.65%[2] Fund Performance - The China Europe A500 Enhanced Index Fund has achieved a cumulative return of 25.94% since its establishment, outperforming the A500 Index by 7.73%[46] - The fund ranks second among eight similar A500 enhanced funds in terms of performance since inception[46] - The fund's annualized excess return is approximately 11.1%, with a 1-month and 3-month performance ranking first among peers[6] Investment Strategy - The fund employs a "active + quantitative" management model, integrating subjective research with quantitative tools to enhance alpha generation[21] - The investment philosophy is based on GARP (Growth at a Reasonable Price), focusing on identifying quality companies with growth potential within reasonable price ranges[31] - The fund maintains a high index tracking ratio while leveraging active stock selection to contribute diversified alpha, with a correlation of daily excess returns to similar funds generally below 0.4 over the past six months[46] Risk Factors - Key risk factors include macroeconomic downturns, increased stock market volatility, and unexpected tightening of financial regulations[5] - The fund is classified as a high-risk, high-reward equity fund, and past performance does not guarantee future results[5] Fund Composition - As of mid-2025, the fund's total scale is 4.4 billion yuan, with a stock position of 92.73%[55] - The fund is diversified across various sectors, with significant allocations to machinery, agriculture, electronics, and utilities, while underweighting sectors like non-ferrous metals and transportation[55]

Core Insights - The recovery of market conditions and increased capital activity have led to a significant positive performance of equity funds, with over 97% achieving positive returns this year, and 81 funds doubling their performance [1][6][7] - Institutional investors are heavily investing in the CSI 300 ETF, while fund management companies are increasing their investments in their own pension funds, indicating confidence in long-term strategies [1][6][7] Institutional Investor Holdings - As of mid-2025, the top 20 equity funds held by institutional investors are predominantly ETFs, with a strong focus on broad-based ETFs like the CSI 300 ETF [3][4] - The top four funds held by institutions are all tracking the CSI 300 index, with the Huatai-PB CSI 300 ETF leading with over 300 billion yuan in holdings [6][7] - Institutional investors are showing a preference for funds with high liquidity and broad market coverage, particularly in the context of the recent market recovery [7][8] Fund Management Company Holdings - Fund management companies are significantly investing in their own pension funds, with several pension FOFs appearing in the top holdings [18][19] - The top fund held by management companies is the Huatai-PB MSCI China A50 ETF, which has shown strong performance with a 22.51% increase this year [21][23] Employee Holdings - Employees of fund management companies exhibit diverse investment preferences, with a mix of value and growth strategies being favored [34] - Certain funds are exclusively available to institutional investors, resulting in 100% holdings by fund management companies for specific products [11][26] Changes in Holdings - There has been a notable increase in holdings for the CSI 300 ETFs and other technology-focused ETFs, reflecting a trend towards sectors with high growth potential [12][13] - Conversely, some funds have experienced significant redemptions, particularly those with a conservative investment strategy [31][32]